CONTACT
CATALOG PRODUCT FINDER
SEARCH BY KEYWORD:
SEARCH BY SCIENTIFIC FIELD:
Amyloid Beta A4 Peptides
Single Peptides: Amyloid beta A4 (abeta) Peptides
Selection of Beta-Amyloid Peptides including various natural variants and biotinylated peptides. All of JPT's amyloid peptides are HFIP treated ensuring full functionality.
Not found what you were looking for? Please proceed to our Custom Peptide Synthesis service.
| Item 1 thru 20 of 54 | Pages: [1][2][3] | |
| next » | last page »» |
Code
Product Name
Price
Buy
Loading. Please wait
SP-Ab-12_0.1
A21G-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (natural variant)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (natural variant)
SP-Ab-12_0.5
A21G-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (natural variant)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (natural variant)
SP-Ab-28_0.1
A2T-Beta-Amyloid (1-40); HFIP treated (0.1mg)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Threonine (Thr)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Threonine (Thr)
SP-Ab-28_0.5
A2T-Beta-Amyloid (1-40); HFIP treated (0.5mg)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Threonine (Thr)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Threonine (Thr)
SP-Ab-25_0.1
A2T-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Threonine (Thr)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Threonine (Thr)
SP-Ab-25_0.5
A2T-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Threonine (Thr)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Threonine (Thr)
SP-Ab-27_0.1
A2V-Beta-Amyloid (1-40); HFIP treated (0.1mg)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Valine (Val)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Valine (Val)
SP-Ab-27_0.5
A2V-Beta-Amyloid (1-40); HFIP treated (0.5mg)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Valine (Val)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Valine (Val)
SP-Ab-26_0.1
A2V-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Valine (Val)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Valine (Val)
SP-Ab-26_0.5
A2V-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Valine (Val)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Valine (Val)
SP-Ab-20_0.1
Beta-Amyloid (1-37); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-20_0.5
Beta-Amyloid (1-37); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-21_0.1
Beta-Amyloid (1-38); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-21_0.5
Beta-Amyloid (1-38); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-32-0.1
Beta-Amyloid (1-40) Scrambled; HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
SP-Ab-32-0.5
Beta-Amyloid (1-40) Scrambled; HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
SP-Ab-18_0.1
Beta-Amyloid (1-40)-Lys(Biotinoyl); HFIP (0.1mg)
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-18_0.5
Beta-Amyloid (1-40)-Lys(Biotinoyl); HFIP (0.5mg)
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-06_0.1
Beta-Amyloid (1-40); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-06_0.5
Beta-Amyloid (1-40); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
| Item 1 thru 20 of 54 | Pages: [1][2][3] | |
| next » | last page »» |
News
- New Protemics Brochure online!
Check to see our latest peptide-driven innovations for proteomics - Improve your Assays with PTM Reference Peptide Standards
Use our 30 NEW SpikeMixTM PTM Reference Pools!
(June 2018) -
Superior Positive Control Pools for Better T-Cell Assays
NEW Peptide Pools available: CEFX 90%, EFX 90%, CEFX MHC-I & MHC-II Subsets
(May 2018)
Quality Assurance
All production is performed according to ISO 9001:2015 standards.
